PET/CT scans for follow-up of stage III lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial is testing whether adding a PET/CT scan to routine follow-up care helps patients with stage III non-small cell lung cancer. It aims to see if this extra imaging can detect any return of cancer earlier, which may help with treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage III non-small cell lung cancer that was confirmed with a biopsy or cell sample before starting treatment.
- You have completed treatment aimed at curing the cancer and have started follow-up care.
- You are 18 years old or older.
- You are in fairly good health (able to care for yourself, up and about more than half of waking hours).
- You are willing to give written permission to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special scan (68Ga-grazytracer PET) to see how well immunotherapy works for stage III non-small cell lung cancer before surgery or radiation. It aims to help doctors choose the best treatment for you.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This study uses a special PET/CT scan that targets a protein called c-Met to help diagnose and stage non-small cell lung cancer. It aims to see if this imaging method can better identify tumor locations and characteristics.
This trial compares a two-step nuclear imaging scan (SPECT/CT) versus a PET/CT scan to see which works better for lung cancer. It may help guide doctors on the most useful imaging approach before you start lung-cancer treatment.
This study compares two types of scans (a special PET/CT called F-18 FDG and regular CT) to see how well they show the extent of non-small cell lung cancer before any treatment starts. It may help doctors choose the right approach for your care.
Hear when a new Stage III Non-small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.